Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

NCT07011589 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa (EB)
Epidermolysis Bullosa Acquisita
Recessive Dystrophic Epidermolysis Bullosa
Dystrophic Epidermolysis Bullosa

Interventions

BIOLOGICAL: Efgartigimod

Sponsor

M. Peter Marinkovich

Collaborators

[object Object]